March 2, 2026 — Ascend Cardiovascular has launched its re-imagined pediatric cardiology product, a comprehensive solution specifically designed to meet the unique, lifelong demands of congenital heart disease (CHD) care — from fetal through adulthood. By combining modernized Mullins diagrams with an integration-first architecture, ASCEND is ending the era of “good enough” legacy systems for pediatric programs.
For decades, pediatric cardiology has been underserved by rigid, imaging-centric platforms that fail to capture the complexity of congenital heart disease. Ascend’s new offering replaces these workflows with a multi-modality reporting platform that connects the entire cardiovascular ecosystem — from cardiac catheterization and EP to fetal and pediatric echocardiography.
A Modern Approach
At the heart of the pediatric offering is a modernized, interactive Mullins atlas. Unlike static legacy illustrations, Ascend’s SVG-designed diagrams allow clinicians to:
- Tailor Patient Anatomy: Add, resize and edit devices like ASD/VSD closure devices, stents and coils to reflect patient-specific conditions.
- Automate Data Entry: Populate diagrams with hemodynamic measurements (pressures, saturations, and calculations)
- Utilize Advanced Editing: Use specialized tools for documenting conduits, shunts and ligatures to accurately capture complex procedural anatomy and outcomes.
A Consolidated Solution
Congenital heart disease is a lifelong journey, and Ascend’s architecture ensures that care is never compromised as patients transition through different life phases. By consolidating data from the moment of fetal or neonatal diagnosis throughout adulthood, Ascend creates a rich, longitudinal data foundation that enables proactive and targeted care that can be leveraged to:
- Streamline Workflows: Support multi-modality workflows across fetal, pediatric, and adult congenital care to deliver seamless, specialized care throughout every stage of life.
- Manage Aging CHD Populations: As pediatric patients reach adulthood, the system tracks historical surgical data that can be used to recommend adult-congenital procedures, such as TAVR or complex electrophysiology mappings for arrhythmia management.
- Simplify Device Integrations: Automate data ingestion directly from DICOM SR, VMS+, hemodynamic systems, and other specialized pediatric devices to improve accuracy and allow clinicians to spend more time with patients and less time on documentation.
“Cardiology deserves more than adaptation; it deserves intention,” said Dr. Jeff Soble, CEO of Ascend Cardiovascular. “We believe pediatric cardiology programs should never have to choose between their clinical history and modern capability. Our solution provides the clinical depth required for CHD while leveraging existing enterprise investments in EHR and imaging systems.”
Remote Collaboration
Recognizing that pediatric expertise is often concentrated in specialized centers, Ascend has created Catalyst telepresence, which transforms how pediatric care can be delivered across distances, providing:
- Real-Time Specialist Consultation: Clinicians can consult with remote pediatric sub-specialists in real time, as if they were physically present in the room. This enriches clinician-to-clinician collaboration and allows for more meaningful, immediate interactions between specialists and the patient’s family.
- Remote Imaging Oversight: Cardiologists can remotely oversee image acquisition for pediatric procedures. By ensuring that every necessary view is captured with diagnostic-grade quality the first time, Catalyst reduces overall procedure time, saves valuable cardiologist time, and—most importantly—eliminates the need for stressful re-imaging sessions for young patients.
Advancing CHD Care with AI
The impact of this offering is further amplified when combined with advanced AI solutions to provide a complete, intelligent end-to-end reading and reporting workflow that addresses the most persistent challenges in clinical practice.
By pairing Ascend’s structured reporting and zero-footprint DICOM viewer with Ventripoint’s AI-based diagnostic technologies, the combined solution delivers a level of clinical insight previously unavailable in standard workflows. This synergy powers the construction of a 3D model of the heart generated from 2D echo data, enabling calculation of volumes and ejection fractions for all chambers with accuracy comparable to MRI, providing a critical diagnostic alternative for young CHD patients who may not tolerate or have access to traditional cardiac MR. This partnership represents a shared commitment to novel solutions that ensure pediatric specialists have the technical expertise and research-grade capabilities required for complex heart analysis.
November 14, 2025 
